Abstract:The telomere-associated protein tankyrase is a poly(adenosine diphosphate-ribose) polymerase and is considered to be a promising target for cancer therapy, especially selective lethality on breast cancer associated (BRCA) cell lines, including breast cancer as well as malignancies of the ovaries, pancreas, and prostate gland. A variety of drug candidates have been developed and investigated, such as XAV-939, which was identified as a tankyrase inhibitor during screening for a small-molecule inhibitor of the Wnt/beta-catenin pathway, and it exhibits nanomolar activity in the tankyrase-2 biochemical assay. Coincidentally, almost all compounds which exhibit excellent activity in the tankyrase-2 biochemical assay showed the common structure: lactam ring or amide structure. According to the reported co-crystal structure of inhibitors with tankyrase-2 analysis, it was found that the lactam ring or amide of the compounds forms three conserved hydrogen bonds to Gly1032 and Ser1068 and a p-stacking interaction with Tyr1071. Thus the lactam ring or amide was identified to be a key structure of tankyrase inhibitors. So a new class of structure based on benzo[f][1,4] oxazepinone scaffold was designed through computer-aided virtual drug screening, and 12 new compounds were synthesized via Mannich reactions of aromatic aldehydes with aromatic amines and aromatic ketones, ring expansion, reduction and condensation. The target compound was confirmed by H-1 NMR, C-13 NMR, HRMS. Followed by the methyl thiazolyl tetrazolium (MTT) assay to test in vitro anti-tumor activity, part compounds showed potent inhibitory effect on tumor cells. This study culminates in compound 3h, an inhibitor with potent activity against Hep-3B (IC50 = 3.5 mu mol/L). Here, the synthesis and structure-activity relationship (SAR) of this novel series were described. To explore the anti-tumor mechanism of benzo[f][1,4] oxazepinone compounds, we explored the interaction of the compound 3h complex with the Gly1032, Ser1068 and Tyr1071 binding site of tankyrase-2, which confirms the three conserved hydrogen and p-stacking binding mode, as supporting information for the in vitro anti-tumor activity.

Identification of 1,4-Benzodiazepine-2,5-dione Derivatives As Potential Protein Synthesis Inhibitors with Highly Potent Anticancer Activity.

Design, Synthesis, and Biological Evaluation of Novel Benzodiazepine Derivatives As Anticancer Agents Through Inhibition of Tubulin Polymerization in Vitro and in Vivo

Discovery of Novel Benzimidazole and Indazole Analogues As Tubulin Polymerization Inhibitors with Potent Anticancer Activities.

Synthesis, Biological Evaluation and Molecular Docking of Benzimidazole Grafted Benzsulfamide-Containing Pyrazole Ring Derivatives As Novel Tubulin Polymerization Inhibitors.

Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway

Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives As Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation

Discovery of 1-(5-(1H-benzo[d]imidazole-2-yl)-2,4-dimethyl-1H-pyrrol-3-yl)ethan-1-one derivatives as novel and potent bromodomain and extra-terminal (BET) inhibitors with anticancer efficacy

Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.

Design, Synthesis and Biological Evaluation of Nitrogen-Containing Macrocyclic Bisbibenzyl Derivatives As Potent Anticancer Agents by Targeting the Lysosome.

Discovery of Novel 1,5-Benzodiazepine-2,4-dione Derivatives As Potential Anticancer Agents.

Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2'-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors

Discovery and Optimization of Novel 4-Morpholinothieno[3,2-d]pyrimidine Derivatives As Potent Bet Inhibitors for Cancer Therapy

Benzothiazoles Exhibit Broad-Spectrum Antitumor Activity: Their Potency, Structure–activity and Structure–metabolism Relationships

Synthesis and Anticancer Activity Evaluation of Benzo[F][1,4] Oxazepinone Derivatives

A Cell-Based Screen for Anticancer Activity of 13 Pyrazolone Derivatives

Design, Synthesis and Biological Evaluation of Novel 6-Phenyl-1,3a,4,10b-tetrahydro-2h-benzo[c]thiazolo[4,5-e]azepin-2-one Derivatives As Potential BRD4 Inhibitors.

Design, Synthesis, and Evaluation of <i>o</i>-(Biphenyl-3-ylmethoxy)nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy <i>In Vivo</i>

A Novel Series of Benzothiazepine Derivatives As Tubulin Polymerization Inhibitors with Anti-Tumor Potency.

Design, Synthesis, and Bioevaluation of Pyrazolo[1,5-A]pyrimidine Derivatives As Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site with Potent Anticancer Activities.

Design, synthesis and mechanism of action of novel 1,9-disubstituted beta-carboline derivatives as antitumor agents